Subscribe To

Price Alert Latest News Economic Calendar News

PLSE / Pulse Biosciences Schedules Fourth Quarter and Full Year 2021 Financial Results Conference Call for March 31, 2022

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, announced today it will report financial results for the fourth quarter and full year of 2021 after market close on Thursday, March 31, 2022. Company management will host a corresponding conference call beginning at 1:30pm Pacific Time. Investors interested in listening to the conference call may d Read More

Demo Live Account See Partner Details

Content Topics

Pulse

Biosciences

Schedules

Fourth

Quarter

Full

Year

2021

Financial

Results

Conference

Stock

PLSE

Posted: Mar 21 2022, 16:05

Author Name: Business Wire

PLSE News

By Seeking Alpha
August 10, 2023

Pulse Biosciences Inc. (PLSE) Q2 2023 Earnings Call Transcript

Pulse Biosciences Inc. (NASDAQ:PLSE ) Q2 2023 Results Conference Call August 10, 2023 4:30 PM ET Company Participants Philip Taylor - IR Kevin Danahy

By Seeking Alpha
May 11, 2023

Pulse Biosciences, Inc. (PLSE) Q1 2023 Earnings Call Transcript

Pulse Biosciences, Inc. (NASDAQ:PLSE ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Trip Taylor - Investor Relations

By Seeking Alpha
March 30, 2023

Pulse Biosciences Inc. (PLSE) Q4 2022 Earnings Call Transcript

Pulse Biosciences Inc. (NASDAQ:PLSE ) Q4 2022 Earnings Conference Call March 30, 2023 4:30 PM ET Company Participants Trip Taylor – Investor Relatio

By Seeking Alpha
August 10, 2022

Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q2 2022 Results - Earnings Call Transcript

Pulse Biosciences, Inc. (NASDAQ:PLSE ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Philip Taylor - Investor Relat

By Zacks Investment Research
August 10, 2022

Pulse Biosciences, Inc (PLSE) Reports Q2 Loss, Lags Revenue Estimates

Pulse Biosciences, Inc (PLSE) delivered earnings and revenue surprises of 0% and 52.17%, respectively, for the quarter ended June 2022. Do the numbers

By Seeking Alpha
May 11, 2022

Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q1 2022 Results - Earnings Call Transcript

Pulse Biosciences, Inc. (NASDAQ:PLSE ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Philip Taylor - Investor Relation

By Seeking Alpha
March 31, 2022

Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q4 2021 Results - Earnings Call Transcript

By Zacks Investment Research
March 31, 2022

Pulse Biosciences, Inc (PLSE) Reports Q4 Loss, Lags Revenue Estimates

Pulse Biosciences, Inc (PLSE) delivered earnings and revenue surprises of 22% and 6.22%, respectively, for the quarter ended December 2021. Do the num

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.